The effect of isolated tumor cells on adjuvant treatment decisions for patients with endometrial cancer: A retrospective case series
Although patients with ITCs were more likely to receive adjuvant treatment, this was accounted for by other clinical and histological factors. Clinicians were likely to make decisions based on established risk factors, and more data are needed on the role of ITCs in the landscape of molecularly based decision making.
Authors
- Naaman Mehta
- Camryn Kenkel (ORCID: https://orcid.org/0009-0003-5248-9661)
- Leslie R. Boyd (ORCID: https://orcid.org/0000-0001-8955-3231)
- Sarah S. Lee (ORCID: https://orcid.org/0000-0002-6752-834X)
- Jude Nawlo (ORCID: https://orcid.org/0009-0004-0465-1035)
- Edward Jimenez (ORCID: https://orcid.org/0000-0001-7584-533X)
Institutions
- Gynecologic Oncology Group (US)
- NYU Langone Health (US)
- New York University (US)
Publication Details
- Journal
- Gynecologic Oncology Reports
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1016/j.gore.2025.101713
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00